A 3-Year Split-Mouth Randomized Controlled Clinical Trial of Zirconia and Titanium Implant-Supported Overdentures
Journal of Functional Biomaterials · 01.05.2026 · 17 (5) · 213
DOI: 10.3390/jfb17050213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Biomaterials, online erschienen am 01.05.2026. Verfasst von Kristian Kniha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Cranio-Maxillofacial Surgery, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ITI research grant.
Abstract (Originalsprache)
Aim
This study aimed to compare two-piece zirconia and two-piece titanium implants inserted into the anterior mandible for removable overdentures in a 3-year randomized split-mouth clinical trial.
Methods
Twenty fully edentulous mandibular patients received two zirconia and two titanium implants allocated by computer-generated randomization. The primary endpoint was bleeding-on-probing (BOP) at 12 months. Secondary outcomes included implant survival and success (Albrektsson criteria), marginal bone level changes, peri-implant cytokines (IL-1β, IL-6, and TNFα), prosthetic complications, and patient-reported outcomes (PROMs).
Results
After 3 years, overall survival was 98.61% and overall success was 84.72%. Titanium implants showed higher success compared with zirconia implants (91.70% vs. 77.78%), while survival was 100% and 97.22%, respectively. Marginal bone loss was significantly greater around zirconia implants at 36 months (p < 0.01). No significant differences were observed in IL-1β, IL-6, or TNFα levels up to 12 months. PROMs revealed a trade-off, with zirconia favored for esthetics and cleaning perception, while titanium was rated superior for stability.
Conclusions
Within the limitations of this split-mouth RCT, zirconia implants demonstrated reduced success and inferior marginal bone stability compared with titanium implants in overdenture therapy. Careful case selection and close follow-up appear essential when zirconia implants are used in this indication.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Cranio-Maxillofacial Surgery, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
- Private Dental Clinic, Dres. Kniha, Rosental 6, 80331 Munich, Germany.
- Institute of Immunology, University Hospital RWTH Aachen, Pauwelstraße 30, 52074 Aachen, Germany.
- Department of Dentistry, Section of Orthodontics, Dentofacial Orthopedics and Craniofacial Biology, Radboud University Medical Centre, THK 309, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
ORCID-Profile: Kristian Kniha, Lothar Rink, Mark Ooms, Stephan Christian Möhlhenrich, Ali Modabber, Marius Heitzer
Förderung
- ITI research grant
Zitieren
APA
Kniha, K., Rink, L., Ooms, M., Schaffrath, K., Möhlhenrich, S. C., Hölzle, F., Modabber, A., & Heitzer, M. (2026). A 3-Year Split-Mouth Randomized Controlled Clinical Trial of Zirconia and Titanium Implant-Supported Overdentures. Journal of Functional Biomaterials, 17(5), 213. https://doi.org/10.3390/jfb17050213
Vancouver
Kniha K, Rink L, Ooms M, Schaffrath K, Möhlhenrich SC, Hölzle F, et al. A 3-Year Split-Mouth Randomized Controlled Clinical Trial of Zirconia and Titanium Implant-Supported Overdentures. Journal of Functional Biomaterials. 2026;17(5):213. doi:10.3390/jfb17050213
BibTeX
@article{Kniha2026,
author = {Kniha, Kristian and Rink, Lothar and Ooms, Mark and Schaffrath, Katharina and Möhlhenrich, Stephan Christian and Hölzle, Frank and Modabber, Ali and Heitzer, Marius},
title = {A 3-Year Split-Mouth Randomized Controlled Clinical Trial of Zirconia and Titanium Implant-Supported Overdentures},
journal = {Journal of Functional Biomaterials},
year = {2026},
volume = {17},
number = {5},
pages = {213},
doi = {10.3390/jfb17050213}
}
EUVIMED